pentobarbital sodium (Sagent Pharmaceuticals)
Welcome to the PulseAid listing for the pentobarbital sodium drug offered from Sagent Pharmaceuticals. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sagent Pharmaceuticals |
| NON-PROPRIETARY NAME: | pentobarbital sodium |
| SUBSTANCE NAME: | PENTOBARBITAL SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAMUSCULAR; INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-04-19 |
| END MARKETING DATE: | 0000-00-00 |
pentobarbital sodium HUMAN PRESCRIPTION DRUG Details:
| Item Description | pentobarbital sodium from Sagent Pharmaceuticals |
| LABELER NAME: | Sagent Pharmaceuticals |
| DEA SCHEDULE: | CII
|
| ACTIVE STRENGTH: | 50(mg/mL) |
| START MARKETING DATE: | 2017-04-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 25021-676_5eb44748-b3d4-4d86-a172-9f03eb804671 |
| PRODUCT NDC: | 25021-676 |
| APPLICATION NUMBER: | ANDA206404 |
Other PENTOBARBITAL SODIUM Pharmaceutical Manufacturers / Labelers:
